Bioactive Compounds
-
BA2793 9-ING-41Summary: 9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective inhibitor of glycogen synthase kinase-3β. -
C6291 2-MethylpyrazineSummary: A research reagent used to modulate cellular signaling pathways and enzyme activity. -
B7926 CephalothinSummary: Inactivates penicillin-binding proteins (PBP) -
B4748 OxiracetamTarget: GABA receptorsSummary: cyclic derivative of gamma-aminobutyric acid (GABA) -
C3990 Lofexidine (hydrochloride)Summary: α2-adrenergic receptor agonist -
N1289 VindolineSummary: Monomeric vinca-alkaloid -
B4656 NeuropathiazolSummary: Selective inducer of neuronal differentiatio -
B1854 Ticarcillin sodiumSummary: semisynthetic antibiotic -
B6900 SB 258585 hydrochlorideSummary: 5-HT6 receptor antagonist -
C8490 JTV-519 hemifumarate

